Clairfield Türkiye & Doalis Strategy
Scaling Assets. Navigating Global Capital.
Strategy is not just about a roadmap; it is about the transaction power that brings a vision to life. At Doalis Strategy, we adhere to a simple principle: “Fewer decisions—and make them count.”
By aligning our execution-focused strategy with Clairfield Türkiye’s immense global M&A network, we are creating a high-performance engine for pharmaceutical companies and biotech innovators. Clairfield’s presence in over 30 countries combined with our deep industry intelligence means that we don’t just find partners; we engineer cross-border synergies that maximize enterprise value.
What this partnership brings to the table:
Global Deal Execution: Seamlessly connecting Turkish pharma assets with international capital.
Transaction Excellence: Merging Doalis’ operational de-risking with Clairfield’s financial advisory expertise.
Strategic Growth: Moving beyond borders to secure a seat at the global mid-market table.
We don’t just plan the move. We execute the deal.
Strategic Execution. Global Synergy.